These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 321161)

  • 21. Preoperative cell-mediated immune status of gastric cancer patients.
    Orita K; Miwa H; Fukuda H; Yumura M; Uchida Y
    Cancer; 1976 Dec; 38(6):2343-8. PubMed ID: 793709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular immunity in asbestosis.
    Lange A; Smolik R; Chmielarczyk W; Garncarek D; Gielgier Z
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):899-903. PubMed ID: 373690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cellular immunity in leprosy patients].
    de Arruda MS; de Arruda OS; Fleury RN; Garcia Dde O; Opromolla DV; Ura S
    Med Cutan Ibero Lat Am; 1982; 10(4):231-8. PubMed ID: 6763656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunological dysfunction in paroxysmal nocturnal haemoglobinuria.
    Vellenga E; Mulder NH; The TH
    Clin Lab Haematol; 1981; 3(4):307-16. PubMed ID: 7333062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunocompetence and its modification after BCG immunotherapy in patients with colon carcinoma.
    Pacheco-Rupil B; Depiante M; Yantorno C; Nuñez P; Casadio B
    Acta Gastroenterol Latinoam; 1980; 10(4):277-82. PubMed ID: 7270013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical studies of methanol extraction residue fraction of Bacillus Calmette-Guérin as an immunostimulant in patients with advanced cancer.
    Moertel CG; Ritts RE; Schutt AJ; Hahn RG
    Cancer Res; 1975 Nov; 35(11 Pt 1):3075-83. PubMed ID: 1102082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic mucocutaneous candidiasis accompanied by enhanced antibody production.
    Takeya K; Nomoto K; Matsumoto T; Miyake T; Himeno K
    Clin Exp Immunol; 1976 Sep; 25(3):497-500. PubMed ID: 786522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cellular immunity in protein-caloric malnutrition].
    Khadraoui S; Lopez V; Hamza B; Smith NJ
    Arch Fr Pediatr; 1977 Feb; 34(2):143-53. PubMed ID: 405954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of transfer factor on lymphocyte function in anergic patients.
    Kirkpatrick CH; Rich RR; Smith TK
    J Clin Invest; 1972 Nov; 51(11):2948-58. PubMed ID: 5080419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cellular immunity indices in benign breast tumors].
    Baisheva SA; Zhalgasbaeva GT; Kaliev IuSh; Mezinova NN
    Vopr Onkol; 1980; 26(5):15-9. PubMed ID: 7385708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutaneous antigen-stimulating lymphokine production by lymphocytes of patients with progressive systemic sclerosis (scleroderma).
    Kondo H; Rabin BS; Rodnan GP
    J Clin Invest; 1976 Dec; 58(6):1388-94. PubMed ID: 791970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Demonstration of lymphocyte blastogenesis--inhibiting factors in sera of melanoma patients.
    Rangel DM; Golub SH; Morton DL
    Surgery; 1977 Aug; 82(2):224-32. PubMed ID: 877866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amphotericin B and 5-fluorocytosine: effects on cell-mediated immunity.
    Roselle GA; Kauffman CA
    Clin Exp Immunol; 1980 Apr; 40(1):186-92. PubMed ID: 6993075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunological behaviour following rubella infection.
    Niwa Y; Kanoh T
    Clin Exp Immunol; 1979 Sep; 37(3):470-6. PubMed ID: 509780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
    Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
    J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Secondary immunodeficiency in miliary tuberculosis.
    Uberoi S; Malaviya AN; Chattopadhyay C; Kumar R; Shrinivas
    Clin Exp Immunol; 1975 Dec; 22(3):404-8. PubMed ID: 1083782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.
    Matchett KM; Huang AT; Kremer WB
    J Clin Invest; 1973 Aug; 52(8):1908-17. PubMed ID: 4541673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro evidence of normal lymphocyte function in some patients with Hodgkin's disease and negative delayed cutaneous hypersensitivity.
    Churchill WH; Rocklin RR; Moloney WC; David JR
    Natl Cancer Inst Monogr; 1973 May; 36():99-106. PubMed ID: 4583000
    [No Abstract]   [Full Text] [Related]  

  • 40. Immune function of successfully treated lymphoma patients.
    King GW; Yanes B; Hurtubise PE; Balcerzak SP; LoBuglio AF
    J Clin Invest; 1976 Jun; 57(6):1451-60. PubMed ID: 932190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.